Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Yes, Melanotan-1 (afamelanotide) received FDA approval in 2019 under the trade name SCENESSE for erythropoietic protoporphyria (EPP), a rare genetic disorder causing extreme photosensitivity and severe pain upon sun exposure
Get in touch with us to get your problem sorted
Before self-diagnosing yourself, see a doctor to eliminate the possibility of other disorders
Mader TH, Gibson CR, Otto CA, Sargsyan AE, Miller NR, Subramanian PS, et al
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
